Skip to main content
LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.030
+0.041 (4.16%)
At close: Dec 20, 2024, 4:00 PM
1.090
+0.060 (5.83%)
After-hours: Dec 20, 2024, 7:32 PM EST

LAVA Therapeutics Revenue

LAVA Therapeutics had revenue of $7.35M in the twelve months ending September 30, 2024, down -18.89% year-over-year. In the year 2023, LAVA Therapeutics had annual revenue of $6.77M, down -65.09%.

Revenue (ttm)
$7.35M
Revenue Growth
-18.89%
P/S Ratio
3.80
Revenue / Employee
$198,514
Employees
37
Market Cap
27.09M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.77M-12.62M-65.09%
Dec 31, 202219.39M14.04M262.45%
Dec 31, 20215.35M1.60M42.78%
Dec 31, 20203.75M--
Jan 1, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

LVTX News

More News